SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001047469-20-003954
Filing Date
2020-07-02
Accepted
2020-07-02 16:05:11
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 a2241993zs-3.htm S-3 311023
2 EX-4.6 a2241993zex-4_6.htm EX-4.6 490069
3 EX-4.8 a2241993zex-4_8.htm EX-4.8 150053
4 EX-4.9 a2241993zex-4_9.htm EX-4.9 151055
5 EX-4.10 a2241993zex-4_10.htm EX-4.10 135201
6 EX-5.1 a2241993zex-5_1.htm EX-5.1 29731
7 EX-23.1 a2241993zex-23_1.htm EX-23.1 4337
8 G234723KUI001.JPG g234723kui001.jpg GRAPHIC 2467
9 G777572.JPG g777572.jpg GRAPHIC 19609
10 G286519.JPG g286519.jpg GRAPHIC 86844
  Complete submission text file 0001047469-20-003954.txt   1422859
Mailing Address 450 EAST JAMIE COURT SOUTH SAN FRANCISCO CA 94080
Business Address 450 EAST JAMIE COURT SOUTH SAN FRANCISCO CA 94080 650-595-2595
Atreca, Inc. (Filer) CIK: 0001532346 (see all company filings)

IRS No.: 273723255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-239652 | Film No.: 201009242
SIC: 2834 Pharmaceutical Preparations